Spread the love“`html Ah, Eclipse. For a generation of developers, that name conjures up images of countless hours spent ...

Spread the loveWhen you picture Android development, what’s the first tool that springs to mind? For many, it’s Android Studio, Google’s official integrated development environment (IDE). And for good ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

President Donald Trump is threatening to impose a 100% tariff on imported generic medications, which could raise costs for Americans unless drugmakers can move production to the U.S. by August 2028.

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. prescriptions—won’t stay in the clear for long. In ...

Donald Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, as part of a drive to reduce the country's reliance on imported medicines. One might be ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

The administration has repeatedly said it will impose steep pharmaceutical tariffs but has not followed through on them. By Rebecca Robbins President Trump said on Tuesday evening that he planned to ...

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...

Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...